Pharmacology Journals

Publishes original research, expert reviews, and commentaries on drug resistance in infectious disease and cancer, and novel drugs and strategies to overcome resistance. Covers molecular mechanisms of resistance, clinical manifestations, microbiology, preclinical therapeutics, oncology drug resistance, multidrug resistance (MDR), and circumvention strategies.

The flagship ASPET review journal, publishing authoritative comprehensive reviews on all aspects of pharmacology. Coverage includes biochemical, cellular and receptor pharmacology, drug metabolism and disposition, clinical pharmacology, neuropharmacology, cardiovascular pharmacology, behavioral pharmacology, and toxicology. All reviews are invited by editors or submitted for editorial consideration.

A highly prestigious Adis review journal providing evidence-based single-agent drug evaluations, clinical pharmacology reviews, pharmacoeconomic assessments, and therapeutic guidelines. Covers pharmacodynamics, pharmacokinetics, clinical trial results, safety and tolerability, and the therapeutic place of approved and emerging drugs across all therapeutic areas.

Publishes influential annual invited reviews covering critical advances across the full spectrum of pharmacology and toxicology. Topics encompass drug receptors and signaling, clinical pharmacology, neuropharmacology, drug metabolism and toxicokinetics, molecular toxicology, pharmacogenomics, and emerging areas such as AI in drug discovery and targeted therapies.

An invited-review journal publishing authoritative and comprehensive reviews across the full spectrum of pharmacology and therapeutics, including drug receptor mechanisms, clinical pharmacology, cancer pharmacology, neuropsychopharmacology, immunopharmacology, cardiovascular pharmacology, and emerging therapeutic modalities. Reviews are written by world leaders and provide definitive coverage of their topic.

A high-impact journal of the Italian Pharmacological Society, publishing original research and reviews on pharmacological mechanisms, drug discovery, and therapeutic applications. Covers cancer pharmacology, natural product pharmacology, cardiovascular pharmacology, immunopharmacology, metabolic disease pharmacology, and translational research from bench to bedside.

The official journal of the British Pharmacological Society, publishing original research on pharmacological properties of all types of drugs and endogenous mediators. Covers receptor pharmacology, neuropharmacology, cardiovascular pharmacology, ion channel biology, signal transduction, in vivo and in vitro pharmacology, and the pharmacology of natural compounds. Particularly encourages papers advancing understanding of drug mechanisms at the molecular and cellular level.

The official journal of the American Society for Clinical Pharmacology & Therapeutics (ASCPT), covering the nature, action, efficacy, and evaluation of therapeutics in humans. Publishes original research on quantitative pharmacology, pharmacokinetics/pharmacodynamics modelling, drug-drug interactions, pharmacogenomics, model-informed drug development, and clinical translation of pharmacological findings.

Focuses on the biochemical mechanisms of drug action and toxicity at the molecular and cellular level. Covers enzyme pharmacology, receptor-mediated signaling, nuclear receptor biology, drug metabolism, pharmacological modulation of cell death pathways, ion channels, and the interface of biochemistry and pharmacology in disease states such as cancer, neurodegeneration, and inflammation.

Expert-authored reviews covering drugs in preclinical and early clinical investigation, providing critical evaluation of investigational compounds, mechanisms of action, early clinical data, and future development prospects. Topics include Phase I and Phase II results, novel therapeutic mechanisms, investigational biologics, and comparative pipeline assessments.

Covers experimental biology and pharmacology across multiple disciplines, including molecular pharmacology, cellular mechanisms of disease, neuroscience, cardiovascular biology, and biochemistry. Publishes research on drug mechanisms of action, receptor pharmacology, animal models of disease, natural compound pharmacology, molecular targets in cancer and metabolic diseases, and the biochemical basis of organ function and disease.

A leading multidisciplinary open-access journal covering all areas of pharmacology including basic and clinical pharmacology, medicinal chemistry, pharmacy, and toxicology. Sections include neuropharmacology, cardiovascular and smooth muscle pharmacology, drug metabolism and transport, pharmacogenetics, and pharmacoepidemiology. Particularly strong for translational research and network pharmacology.

Publishes comprehensive reviews and original research on neurological and psychiatric drug discovery, covering neuropharmacology of CNS drugs, receptor biology, neurotransmitter systems, neuroprotection, neuroinflammation, and drug treatment of disorders including Alzheimer's disease, Parkinson's disease, schizophrenia, depression, epilepsy, and pain.

Covers all aspects of experimental and clinical pharmacology, with particular emphasis on molecular pharmacology, receptor biology, neuropharmacology, cardiovascular and metabolic pharmacology, and inflammation. Publishes research in the areas of drug interactions, mechanism-based pharmacology, behavioral pharmacology, and pharmacology of endogenous mediators.

Expert review journal covering metabolic, pharmacokinetic, and toxicological aspects of specific drugs and drug classes. Topics include drug-drug interactions, CYP enzymes, phase I and II metabolism, drug transporters, hepatic and renal drug disposition, bioavailability, population pharmacokinetics, and drug safety assessment methods in specific populations.

An expert review journal covering novel and recently identified molecular drug targets, providing authoritative opinion on their therapeutic potential. Covers target characterization and biological validation, structural biology of disease-relevant targets, and drug discovery opportunities they present across oncology, neurology, cardiology, and infectious disease.

A leading Adis journal dedicated to pharmacovigilance, drug safety monitoring, and adverse drug reactions. Publishes evidence-based reviews, original research, and clinical analyses on drug safety profiles, post-marketing surveillance, risk management, spontaneous reporting systems, pharmacoepidemiological studies, and the regulatory assessment of drug benefits and risks.

A leading ASPET journal published since 1909, providing broad coverage of all aspects of interactions of chemicals with biological systems, including autonomic, behavioral, cardiovascular, cellular, clinical, developmental, gastrointestinal, immuno-, neuro-, pulmonary, and renal pharmacology, as well as drug abuse, metabolism and disposition, chemotherapy, and toxicology.

An ASPET journal publishing findings from the application of structural biology, biochemistry, biophysics, physiology, genetics, and molecular biology to fundamental pharmacological problems, providing mechanistic insights broadly important to pharmacology and toxicology. Covers GPCR biology, ion channel pharmacology, receptor-effector coupling, and molecular mechanisms of drug action.

The official journal of the Japanese Pharmacological Society, publishing original research on all aspects of experimental and clinical pharmacology with a focus on drug discovery and development. Covers receptor pharmacology, pharmacokinetics, molecular mechanisms of drug action, cardiovascular pharmacology, CNS pharmacology, and the pharmacology of natural products.

Official journal of the British Pharmacological Society for clinical pharmacology, covering drug efficacy, safety, tolerability, and pharmacokinetics in humans. Publishes clinical pharmacokinetic studies, drug interaction studies, pharmacogenomic research, pharmacoepidemiology, therapeutic drug monitoring, and clinical trials evaluating drug use in clinical practice.

Official journal of the Japanese Society for the Study of Xenobiotics (JSSX), covering all aspects of xenobiotic metabolism and pharmacokinetics including CYP-mediated drug metabolism, drug transporters, ADME studies, enzyme induction and inhibition, pharmacogenomics relevant to drug disposition, and in vitro-in vivo correlation of metabolic profiles.

Official journal of the French Society of Pharmacology and Therapeutics, bridging fundamental pharmacology research and its clinical applications. Covers receptor pharmacology, pharmacokinetics, pharmacodynamics, drug interactions, cardiovascular pharmacology, and the pharmacological basis of clinical treatments in humans.

Official journal of the Australasian Society, covering original research at the interface of pharmacology and physiology with clinical relevance. Topics include cardiovascular pharmacology, renal physiology and pharmacology, hormonal pharmacology, metabolic physiology, smooth muscle pharmacology, and translational research with applications in human disease management.

Covers all aspects of clinical pharmacology and drug therapy in humans, including pharmacokinetics, pharmacodynamics, therapeutic drug monitoring, drug safety, pharmacoepidemiology, pharmacogenetics, and evidence-based drug therapy. Publishes clinical trials, observational studies, drug interaction studies, bioequivalence trials, and systematic reviews on drugs in clinical use.

Official journal of the Nordic Pharmacological Society, publishing research that bridges basic pharmacology and clinical pharmacology with toxicology. Covers pharmacokinetics, drug safety, clinical toxicology, pharmacoepidemiology, adverse drug reactions, drug interactions, and experimental pharmacology studies with clear translational relevance.

One of the oldest pharmacology journals (established 1873), now covering neuropharmacology, cardiovascular pharmacology, molecular pharmacology, and exploring drug actions at cellular, biochemical, and molecular levels. Also publishes in the fields of molecular phytopharmacology, immunopharmacology, and pharmacology of malignant diseases, as well as clinical pharmacology and pharmacovigilance.

A Karger journal covering all areas of pharmacology, including receptor pharmacology, autonomic pharmacology, cardiovascular pharmacology, neuropharmacology, and endocrine pharmacology. Accepts original research articles and reviews focusing on pharmacological mechanisms, drug action profiles, and therapeutic implications of pharmacological interventions.

Covers the molecular aspects of pharmacological research, including molecular drug targets, receptor molecular biology, signal transduction pathways in disease, molecular mechanisms of drug action, pharmacogenomics, and the application of molecular biology tools to pharmacological problems. Publishes reviews and research on genomic and proteomic approaches to drug discovery.